Cited by 18Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementGynecological conditions and treatments

Seven hormonal biomarkers for diagnosing endometriosis: Meta-analysis and adjusted indirect comparison of diagnostic test accuracy

Gao, Ya, Shen, Minghui, Ma, Xueni, Li, Jipin, Wang, Bo, Wang, Jiancheng, Tian, Jinhui·2019·Journal of Minimally Invasive Gynecology

Abstract

Objective To compare the diagnostic accuracy of different hormonal biomarkers and to find the most effective hormonal biomarker for the diagnosis of endometriosis.Data sources We conducted a systematic search using PubMed, EMBASE, Cochrane Library, and China Biomedical Literature to identify relevant studies from the first day of databases to August 2018.Methods of study selection Two independent reviewers screened for study eligibility and extracted data. Random controlled trials, cross-sectional studies, case-control studies, and cohort studies evaluating the diagnostic accuracy of hormonal markers for endometriosis were included.Tabulation, integration, and results We included 17 studies that involved 1279 participants and evaluated 7 hormonal biomarkers. The pooled sensitivity and specificity in endometriosis were .79 (.71, .86) and .89 (.82, .94) for aromatase, .30 (.18, .46) and .80 (.65, .90) for human chorionic gonadotropin/luteinizing hormone receptor, .75 (.66, .83) and .47 (.34, .60) for estrogen receptor (ER)-α, .65 (.56, .74) and .68 (.55, .80) for ER-β, .45 (.38-.52) and .92 (.85-.97) for serum prolactin, .69 (.51, .83) and .30 (.16, .49) for estrogen sulfotransferase, and .73 (.60-.84) and .48 (.33-.63) for 17β-hydroxysteroid dehydrogenase type 2 (17βHSD2). Compared with human chorionic gonadotropin/luteinizing hormone receptor, ER-α, ER-β, estrogen sulfotransferase, and 17βHSD2, aromatase had a higher sensitivity, specificity, positive likelihood ratio, and diagnostic odds ratio. The specificities of aromatase and serum prolactin were comparable, but the sensitivity, positive likelihood ratio, and positive likelihood ratio of serum prolactin were much lower than that of aromatase.Conclusion Aromatase may be an excellent diagnostic test for endometriosis. However, because of the moderate quality of the included studies and the limited sample size, this result requires more research to validate. (PROSPERO registration number: PROSPERO 2018 CRD42018105126.).

Integrity signals

Registry

Crossref · 10.1016/j.jmig.2019.04.004

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Serum prolactin levels are significantly elevated in women with endometriosis, but prior examinations mainly focused on patients with endometriosis and accompanying infertility.

    “It has also been documented that serum prolactin levels are significantly elevated in women with endometriosis, however, the examinations were mainly focused on patients with endometriosis and accompanying infertility [23,24,25].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gao, Y., Shen, M., Ma, X., Li, J., Wang, B., Wang, J., & Tian, J.
Affiliations
  • Lanzhou University (CN)
  • Lanzhou University Second Hospital (CN)
  • Gansu Provincial Hospital (CN)
Corresponding author
Tian, Jinhui
Venue
Journal of Minimally Invasive Gynecology
Publisher
Elsevier BV
Published
2019-09
Volume
26
Issue
6
Pages
1026-1035.e4
ISSN
1553-4650 (ISSN-L)
OpenAlex
W2935373464
Cited by
18
References
56
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4
FWCI
0.25
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Minimally Invasive Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • Lanzhou University Institutional Repository (submittedVersion)
Funders
Science and Technology Plan Project of Gansu Province (17JR5RA236)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, hormonal biomarkers, diagnostic accuracy, aromatase, estrogen receptor alpha, estrogen receptor beta, serum prolactin, estrogen sulfotransferase, 17β-hydroxysteroid dehydrogenase type 2, indirect comparison, sensitivity and specificity, biomarker selection
MeSH terms
Cross-Sectional Studies, Diagnostic Techniques, Endocrine, Diagnostic Techniques, Obstetrical and Gynecological, Diagnostic Tests, Routine, Endometriosis, Female, Hormones, Humans, Predictive Value of Tests, Sensitivity and Specificity, Reproducibility of Results, Biomarkers, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review